Search Results - Raymond M. Reilly

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (... by Conrad Chan, Vanessa Prozzo, Sadaf Aghevlian, Raymond M. Reilly

    Published in EJNMMI Radiopharmacy and Chemistry (2022-12-01)
    Get full text
    Article


  2. 2

    Auger electrons for cancer therapy – a review by Anthony Ku, Valerie J. Facca, Zhongli Cai, Raymond M. Reilly

    Published in EJNMMI Radiopharmacy and Chemistry (2019-10-01)
    Get full text
    Article


  3. 3

    Bispecific radioimmunoconjugates exploit receptor heterogeneity for positron emission tomography of tumors expressing HER2 and/or EGFR by Luke Yongkyu Kwon, Zhongli Cai, Azza Al-Mahrouki, Raymond M. Reilly

    Published in iScience (2024-05-01)
    Get full text
    Article


  4. 4

    [225Ac]Ac- and [111In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive... by Misaki Kondo, Zhongli Cai, Conrad Chan, Nubaira Forkan, Raymond M. Reilly

    Published in EJNMMI Radiopharmacy and Chemistry (2023-09-01)
    Get full text
    Article


  5. 5

    Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape by Raymond M. Reilly, Constantine J. Georgiou, Madeline K. Brown, Zhongli Cai

    Published in EJNMMI Radiopharmacy and Chemistry (2024-05-01)
    Get full text
    Article


  6. 6

    Estrone-3-sulphate, a potential novel ligand for targeting breast cancers. by Nilasha Banerjee, Humphrey Fonge, Andrew Mikhail, Raymond M Reilly, Reina Bendayan, Christine Allen

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  7. 7

    A radiolabeled antibody targeting CD123+ leukemia stem cells – initial radioimmunotherapy studies in NOD/SCID mice engrafted with primary human AML by Jeffrey V. Leyton, Catherine Gao, Brent Williams, Armand Keating, Mark Minden, Raymond M. Reilly

    Published in Leukemia Research Reports (2015-01-01)
    Get full text
    Article


  8. 8

    Development of an epidermal growth factor derivative with EGFR blocking activity. by Clara Panosa, Francesc Tebar, Montserrat Ferrer-Batallé, Humphrey Fonge, Masaharu Seno, Raymond M Reilly, Anna Massaguer, Rafael De Llorens

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  9. 9

    Auger electron-emitting EGFR-targeted and non-targeted [197Hg]Hg-gold nanoparticles for treatment of glioblastoma multiforme (GBM) by Madeline K. Brown, Zhongli Cai, Constantine J. Georgiou, Shaohuang Chen, Yumeela Ganga-Sah, Valery Radchenko, James T. Rutka, Raymond M. Reilly

    Published in EJNMMI Radiopharmacy and Chemistry (2025-07-01)
    Get full text
    Article


  10. 10

    CD16+NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice by Brent A. Williams, Xing-Hua Wang, Jeffrey V. Leyton, Sonam Maghera, Bishoy Deif, Raymond M. Reilly, Mark D. Minden, Armand Keating

    Published in Haematologica (2018-10-01)
    Get full text
    Article


  11. 11

    SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice by Nasim Sarrami, Bryce Nelson, Samantha Leier, John Wilson, Conrad Chan, Jalna Meens, Teesha Komal, Laurie Ailles, Melinda Wuest, Michael Schultz, Afsaneh Lavasanifar, Raymond M. Reilly, Frank Wuest

    Published in EJNMMI Radiopharmacy and Chemistry (2024-11-01)
    Get full text
    Article


Search Tools: